Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pall BioSupport introduces Accuwik lateral flow medium:

This article was originally published in Clinica

Executive Summary

Pall's BioSupport Division (US) has introduced Accuwik lateral flow transfer medium as a replacement for nitrocellulose in one-step lateral flow diagnostic tests. The microporous, microfibre membrane contains no surfactants, and is intrinsically hydrophilic, requiring no pre-wetting, the company says. Wicking rate is controllable at migration speeds up to five times faster than nitrocellulose, and the medium exhibits very low level protein adsorption. Three grades, each providing two flow rates depending on orientation, are available.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel